These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 908006)

  • 1. Factor XIII deficiency in BALB/c mice with plasmacytoma.
    Eipe J; Yakulis V; Costea N
    Cancer Res; 1977 Oct; 37(10):3551-5. PubMed ID: 908006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imuran-induced regression of plasma cell tumor MOPC-315.
    Schlossberg M; Hollander VP
    Cancer Res; 1973 Aug; 33(8):1953-6. PubMed ID: 4720804
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of iron deficiency on transplantable murine plasmacytoma.
    Benbassat J; Hershko C; Laskov R; Eliakim M
    Nutr Cancer; 1981; 3(1):20-6. PubMed ID: 7346786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of the fibrin-stabilizing blood coagulation factor XIII in hemorrhages after tooth extractions].
    Vogel C
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):137-8. PubMed ID: 6967809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XIII-deficiency in the blood of venous leg ulcer patients.
    Vanscheidt W; Hasler K; Wokalek H; Niedner R; Schöpf E
    Acta Derm Venereol; 1991; 71(1):55-7. PubMed ID: 1676216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acquired factor deficiency: a case report and literature review].
    Chen YF; Xue F; Yang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):662-3. PubMed ID: 23134865
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of factor XIII in fibroblast proliferation.
    Ueyama M; Urayama T
    Jpn J Exp Med; 1978 Apr; 48(2):135-42. PubMed ID: 568677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.
    Barbui T; Cartei G; Chisesi T; Dini E
    Thromb Diath Haemorrh; 1974 Sep; 32(1):124-31. PubMed ID: 4454035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.
    Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A
    Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)].
    Havemann K; Egbring R; Gropp C; Schmidt M; Sodomann CP
    Klin Wochenschr; 1977 Aug; 55(16):801-9. PubMed ID: 269298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of immunosuppressive factor(s) by MOPC-315 murine plasmacytoma cells: a possible mechanism of defence.
    Bomstein Y; Ophir R; Harshemes H; Ben-Efraim S
    Anticancer Res; 1993; 13(6A):2125-9. PubMed ID: 8297124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
    Adler A; Keisari Y; Ofir R
    J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of coagulation factor XIII.
    Israels ED; Paraskevas F; Israels LG
    J Clin Invest; 1973 Oct; 52(10):2398-403. PubMed ID: 4199604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.